Tag Page ATOMICTrial

Immunotherapy Flop in Colon Cancer?

The ATOMIC trial just dropped some surprising news: adding atezolizumab (an immunotherapy) to standard chemo didn’t really help prevent stage III MSI-H/dMMR colon cancer from coming back. While it worked wonders in metastatic cases, it didn’t move the needle much here—except maybe for a few high-risk folks. The combo was safe, though! Looks like chemo alone is still the go-to, but researchers are eyeing new strategies like neoadjuvant immunotherapy and ctDNA tracking. Stay tuned for what’s next! #ColonCancer #Immunotherapy #ATOMICTrial #Oncology #CancerResearch #Health